274 related articles for article (PubMed ID: 23001567)
1. Polycystin-1 regulates the stability and ubiquitination of transcription factor Jade-1.
Foy RL; Chitalia VC; Panchenko MV; Zeng L; Lopez D; Lee JW; Rana SV; Boletta A; Qian F; Tsiokas L; Piontek KB; Germino GG; Zhou MI; Cohen HT
Hum Mol Genet; 2012 Dec; 21(26):5456-71. PubMed ID: 23001567
[TBL] [Abstract][Full Text] [Related]
2. Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL.
Chitalia VC; Foy RL; Bachschmid MM; Zeng L; Panchenko MV; Zhou MI; Bharti A; Seldin DC; Lecker SH; Dominguez I; Cohen HT
Nat Cell Biol; 2008 Oct; 10(10):1208-16. PubMed ID: 18806787
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for renal cancer by the dynamics of pVHL-dependent JADE1 stabilization and β-catenin regulation.
Shafique S; Rashid S
Prog Biophys Mol Biol; 2019 Aug; 145():65-77. PubMed ID: 30528740
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor von Hippel-Lindau (VHL) stabilization of Jade-1 protein occurs through plant homeodomains and is VHL mutation dependent.
Zhou MI; Wang H; Foy RL; Ross JJ; Cohen HT
Cancer Res; 2004 Feb; 64(4):1278-86. PubMed ID: 14973063
[TBL] [Abstract][Full Text] [Related]
5. Candidate tumor suppressor and pVHL partner Jade-1 binds and inhibits AKT in renal cell carcinoma.
Zeng L; Bai M; Mittal AK; El-Jouni W; Zhou J; Cohen DM; Zhou MI; Cohen HT
Cancer Res; 2013 Sep; 73(17):5371-80. PubMed ID: 23824745
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and characterization of the von Hippel-Lindau-like protein.
Qi H; Gervais ML; Li W; DeCaprio JA; Challis JR; Ohh M
Mol Cancer Res; 2004 Jan; 2(1):43-52. PubMed ID: 14757845
[TBL] [Abstract][Full Text] [Related]
7. Polycystin-1 C-terminal tail associates with beta-catenin and inhibits canonical Wnt signaling.
Lal M; Song X; Pluznick JL; Di Giovanni V; Merrick DM; Rosenblum ND; Chauvet V; Gottardi CJ; Pei Y; Caplan MJ
Hum Mol Genet; 2008 Oct; 17(20):3105-17. PubMed ID: 18632682
[TBL] [Abstract][Full Text] [Related]
8. Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway.
Ivanova AV; Ivanov SV; Danilkovitch-Miagkova A; Lerman MI
J Biol Chem; 2001 May; 276(18):15306-15. PubMed ID: 11278694
[TBL] [Abstract][Full Text] [Related]
9. The ciliary protein nephrocystin-4 translocates the canonical Wnt regulator Jade-1 to the nucleus to negatively regulate β-catenin signaling.
Borgal L; Habbig S; Hatzold J; Liebau MC; Dafinger C; Sacarea I; Hammerschmidt M; Benzing T; Schermer B
J Biol Chem; 2012 Jul; 287(30):25370-80. PubMed ID: 22654112
[TBL] [Abstract][Full Text] [Related]
10. von Hippel-Lindau partner Jade-1 is a transcriptional co-activator associated with histone acetyltransferase activity.
Panchenko MV; Zhou MI; Cohen HT
J Biol Chem; 2004 Dec; 279(53):56032-41. PubMed ID: 15502158
[TBL] [Abstract][Full Text] [Related]
11. Jade-1: its structure, regulation and functions in the renal cancer.
Zhang YC; Du WQ; Zhang RY; Zheng JN; Pei DS
Curr Mol Med; 2016; 16(1):63-9. PubMed ID: 26695694
[TBL] [Abstract][Full Text] [Related]
12. pVHL mediates K63-linked ubiquitination of nCLU.
Xue J; Lv DD; Jiao S; Zhao W; Li X; Sun H; Yan B; Fan L; Hu RG; Fang J
PLoS One; 2012; 7(4):e35848. PubMed ID: 22532874
[TBL] [Abstract][Full Text] [Related]
13. Cleavage fragments of the C-terminal tail of polycystin-1 are regulated by oxidative stress and induce mitochondrial dysfunction.
Pellegrini H; Sharpe EH; Liu G; Nishiuchi E; Doerr N; Kipp KR; Chin T; Schimmel MF; Weimbs T
J Biol Chem; 2023 Sep; 299(9):105158. PubMed ID: 37579949
[TBL] [Abstract][Full Text] [Related]
14. USP9X destabilizes pVHL and promotes cell proliferation.
Zhang C; Peng Z; Zhu M; Wang P; Du X; Li X; Liu Y; Jin Y; McNutt MA; Yin Y
Oncotarget; 2016 Sep; 7(37):60519-60534. PubMed ID: 27517496
[TBL] [Abstract][Full Text] [Related]
15. Jade-1, a candidate renal tumor suppressor that promotes apoptosis.
Zhou MI; Foy RL; Chitalia VC; Zhao J; Panchenko MV; Wang H; Cohen HT
Proc Natl Acad Sci U S A; 2005 Aug; 102(31):11035-40. PubMed ID: 16046545
[TBL] [Abstract][Full Text] [Related]
16. Role of the C-terminal alpha-helical domain of the von Hippel-Lindau protein in its E3 ubiquitin ligase activity.
Lewis MD; Roberts BJ
Oncogene; 2004 Mar; 23(13):2315-23. PubMed ID: 14691445
[TBL] [Abstract][Full Text] [Related]
17. The C-terminal tail of polycystin-1 regulates complement factor B expression by signal transducer and activator of transcription 1.
Wu M; Chen M; Jing Y; Gu J; Mei S; Yao Q; Zhou J; Yang M; Sun L; Wang W; Hu H; Wüthrich RP; Mei C
Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1284-94. PubMed ID: 26984954
[TBL] [Abstract][Full Text] [Related]
18. Polycystin-1 regulates STAT activity by a dual mechanism.
Talbot JJ; Shillingford JM; Vasanth S; Doerr N; Mukherjee S; Kinter MT; Watnick T; Weimbs T
Proc Natl Acad Sci U S A; 2011 May; 108(19):7985-90. PubMed ID: 21518865
[TBL] [Abstract][Full Text] [Related]
19. Molecular targets from VHL studies into the oxygen-sensing pathway.
Maynard MA; Ohh M
Curr Cancer Drug Targets; 2005 Aug; 5(5):345-56. PubMed ID: 16101382
[TBL] [Abstract][Full Text] [Related]
20. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
